内生真菌产紫杉醇研究的回顾与展望

紫杉醇是一种高效、低毒、广谱的天然抗癌药物,是人类未来20年间最有效的抗癌药物之一。近年来的研究发现,从植物内生真菌中发酵生产紫杉醇被证明是解决药源问题的有效途径。本文概述了微生物发酵生产紫杉醇的研究进展,包括产紫杉醇内生真菌的分离、多样性和真菌产紫杉醇的优势,紫杉醇的提取和检测技术,同时对如何提高内生真菌紫杉醇产量进行了比较全面的综述。随着现代分子生物学技术和微生物发酵工程的发展,工业上大规模发酵生产紫杉醇将有望实现。     

内生真菌发酵生产紫杉醇的研究现状与展望

抗癌药物紫杉醇已在临床上广泛应用,但受原料红豆杉树木短缺的制约,存在巨大的供需差距,而内生真菌发酵生产紫杉醇是解决紫杉醇药源问题的很有前景的途径之一.结合课题组多年来开展的科学试验研究工作,概述了内生真菌发酵生产紫杉醇的优势、产紫杉醇内生真菌的分离研究现状和生物多样性及提高内生真菌生物合成紫杉醇量的途径.     

微生物发酵生产紫杉醇研究进展

概述了微生物发酵法生产紫杉醇的研究进展,包括产紫杉醇内生真菌的多样性和真菌产紫杉醇的优势,内生真菌分离、紫杉醇纯化和含量测定方法,同时对如何提高内生真菌紫杉醇产量进行了比较全面的综述。     

内生真菌紫杉醇生物合成的研究现状与展望

紫杉醇是重要的抗癌药物之一,已经证明其对多种癌症具有显著疗效。目前,人们主要是从红豆杉的树皮中提取、分离和纯化紫杉醇,但由于红豆杉为生长缓慢、散生、濒危的珍稀植物,且随着紫杉醇临床用途的不断拓宽,市场需求的稳定增长,单纯依靠从红豆杉树皮中提取紫杉醇已经无法满足日益增长的市场需求。为了解决紫杉醇的药源不足,科学家已把目光从红豆杉树分离提取紫杉醇转向了其他替代方法,如化学全合成、半合成、组织培养与细胞培养、微生物发酵法生产紫杉醇等。因此,了解内生真菌紫杉醇生物合成的分子基础和遗传调控机制,对解析内生真菌紫杉醇生物合成机制、构建高产紫杉醇基因工程菌株和早日实现内生真菌紫杉醇工业化生产具有重要的科学意义和现实意义。结合本课题组多年来的科研工作,概述了红豆杉细胞紫杉醇生物合成途径、内生真菌发酵生产紫杉醇的优势、产紫杉醇内生菌的分离研究现状和生物多样性及紫杉醇生物合成相关基因的研究现状。内生真菌生物发酵合成紫杉醇是可以无限生产、大量获取紫杉醇、解决紫杉醇药源短缺问题的很有前景的方法之一。     

内生真菌紫杉醇生物合成的研究现状与展望（英文）

紫杉醇是重要的抗癌药物之一,已经证明其对多种癌症具有显著疗效。目前,人们主要是从红豆杉的树皮中提取、分离和纯化紫杉醇,但由于红豆杉为生长缓慢、散生、濒危的珍稀植物,且随着紫杉醇临床用途的不断拓宽,市场需求的稳定增长,单纯依靠从红豆杉树皮中提取紫杉醇已经无法满足日益增长的市场需求。为了解决紫杉醇的药源不足,科学家已把目光从红豆杉树分离提取紫杉醇转向了其他替代方法,如化学全合成、半合成、组织培养与细胞培养、微生物发酵法生产紫杉醇等。因此,了解内生真菌紫杉醇生物合成的分子基础和遗传调控机制,对解析内生真菌紫杉醇生物合成机制、构建高产紫杉醇基因工程菌株和早日实现内生真菌紫杉醇工业化生产具有重要的科学意义和现实意义。结合本课题组多年来的科研工作,概述了红豆杉细胞紫杉醇生物合成途径、内生真菌发酵生产紫杉醇的优势、产紫杉醇内生菌的分离研究现状和生物多样性及紫杉醇生物合成相关基因的研究现状。内生真菌生物发酵合成紫杉醇是可以无限生产、大量获取紫杉醇、解决紫杉醇药源短缺问题的很有前景的方法之一。     

产紫杉醇真菌的研究概况与紫杉醇工业生产的一个新思路

分离自太平洋红豆杉的天然抗癌药物紫杉醇(Taxol)已在临床上广泛应用,市场需求日益增强,但工业产量受原料红豆杉树木短缺的制约,供需存在巨大差距。1993年,Stierle等分离到一株与太平洋红豆杉共生的真菌安德烈紫杉菌,证实产生紫杉醇,为利用真菌发酵生产紫杉醇带来可能。通过分析目前工业生产技术存在的问题,总结了产紫杉醇真菌研究的进展及其重要意义。认为利用真菌大规模发酵生产紫杉醇或其中间体,是摆脱制约的一条新思路,具有广阔的应用前景,并且可以带动其他产品的开发。     

产紫杉醇植物内生真菌的研究进展

紫杉醇是一种二萜类生物碱,通过抑制微管解聚和稳定微管的作用来抑制有丝分裂,是一种高效、低毒、广谱的天然抗癌药物,已在临床上广泛使用,市场需求量巨大,但由于生产原料的制约,价格十分昂贵。近年来的研究表明,利用植物内生真菌发酵生产紫杉醇是解决药源问题的有效途径。本文就产紫杉醇内生真菌的分离与鉴定方法、紫杉醇的提取与检测技术及在研的菌种进行综述,并进一步提出目前内生真菌源紫杉醇研究存在的问题与前景。     

一株产紫杉醇内生真菌液体发酵工艺的优化

紫杉醇是一种高效、低毒、广谱的天然抗癌药物,可以有效地治疗乳腺癌、子宫癌等。近年来的研究发现,从植物内生真菌中发酵生产紫杉醇被证明是解决药源问题的有效途径。从分离到的420株内生真菌中筛选到一株产紫杉醇的内生真菌XC1-07为实验材料进行发酵条件的初步优化。结果表明：最适碳源、氮源分别是麦芽糖和NH4NO3;在含10g/L NH4NO3、90g/L麦芽糖、1.0g/L MgSO4、pH6的优化培养基中培养13d,紫杉醇的产量为1,124.34μg/L。为目前报道的植物内生真菌发酵生产紫杉醇最高的产量。     

产紫杉醇(Taxol)内生真菌的生物多样性

主要阐述了产紫杉醇内生真菌的分离和生物多样性的研究状况 ,紫杉醇产生菌的生物多样性意义及微生物发酵法生产紫杉醇的研究进展 ,并结合内生真菌的特点 ,阐述了紫杉醇产生菌的宿主、生境和生态以及物种的生物多样性     

南方红豆杉产紫杉醇内生真菌的分离

对从广东乳源县的南方红豆杉(Taxus chinensis var. mairei)内生真菌中分离和筛选产紫杉醇的内生真菌进行了研究。从南方红豆杉的树皮、茎部、叶片及叶片研磨物中分离纯化了145株内生真菌,对其中的53株内生真菌采用摇瓶发酵培养的方法筛选产紫杉醇的内生真菌。发酵物和菌丝体经研磨、离心、乙酸乙酯萃取和浓缩,经硅胶薄层层析(TLC),高效液相色谱(HPLC)以及液相色谱-质谱(HPLC-MS)分析和检测,结果表明,从茎部分离的1株内生真菌能够产紫杉醇或其异构体, 产量达180 μg L^-1。通过对产紫杉醇内生真菌进行诱变、筛选以及优化培养条件等措施,大规模培养生产紫杉醇是具有可行性的。     

真菌代谢产物的药物发现——资源、问题和策略

本期菌物学报“真菌生物活性代谢产物的药物发现专刊”刊登了7篇深度论述的综述性文章,19篇研究论文及2篇简报。内容涉及植物内生真菌产紫杉醇/紫杉烷的研究现状及最新进展、虫草菌素产生菌的培养策略及其药理学研究进展、灵芝三萜和胞外多糖生物合成的调控策略、淡水和海水真菌活性代谢产物研究进展等。本期内容还涉及内生真菌的分离和鉴定、海洋真菌的代谢产物分离、大型真菌的培养、代谢产物的分离及其药理学研究、酚类化合物测定方法、蛋白质组学以及生物转化等研究,基本体现了我国真菌代谢产物新药发现研究的最新进展,对真菌代谢产物合成调控、活性代谢产物分离和结构鉴定以及药理学研究等都具有重要的参考价值。     

Will fungi be the new source of the blockbuster drug taxol?

Taxol (paclitaxel) is widely used for the treatment of various kinds of cancers. Originally, the major source of taxol was bark of the Pacific yew tree (Taxus brevifolia). However, this proved devastating to natural populations of the trees. To protect the Pacific yew, alternatives to the use of trees are sought. One solution is the use of taxol or its precursors derived from fungi. A large number of endophytic fungi that reside within healthy plants have been reported to be taxol producers. However, fungal epiphytes, pathogens and saprophytes have also been found to produce taxol. Several strains of fungi belonging to species Metarhizium anisopliae and Cladosporium cladosporioides MD2 are very promising, producing taxol at levels up to 800 μg/L. This review examines the potential for production of taxol from fungi. The biology of taxol synthesis in fungi and measures which may improve taxol yield are also discussed.     

A review: recent advances and future prospects of taxol-producing endophytic fungi

In the urgent search for more effective ways to treat cancer, new extraction methods of taxol from endophytic fungus have demonstrated high potential in increasing the efficiency of taxol extraction for more efficient and sustainable production of taxol and cancer treatment products. This paper summarizes recent advances in taxol-producing endophytic fungi, both in China and abroad, in the following areas: isolation and identification of endophytic fungi types, extraction and detection methods of endophytic taxol in plants, and improved efficiency of the extraction process. With the advancement of science and technology, new techniques in biotechnology, such as fungal strain improvement and recombining technique and microbial fermentation engineering, have increased the extraction yield from taxol-producing fungi, thereby improved the overall efficiency of taxol production.     

Analysis of β-tubulin cDNAs from taxol-resistant Pestalotiopsis microspora and taxol-sensitive Pythium ultimum and comparison of the taxol-binding properties of their products

The anti-cancer drug taxol binds to β-tubulin in assembled microtubules and causes cell cycle arrest in animal cells; in contrast, in fungi, the effect of taxol varies. For instance, the taxol-producer Pestalotiopsis microspora Ne32, an ascomycete, is resistant to taxol (IC₅₀ greater than 11.7?μM), whereas Pythium ultimum, an oomycete, is sensitive to taxol (IC₅₀ 0.1?μM). In order to understand the differential fungal response to taxol, we isolated cDNAs encoding β-tubulin from both P. microspora and P. ultimum. The deduced amino acid sequence of β-tubulin from P. microspora is very similar to those from other Ascomycetes, many of which are resistant to taxol. The sequence of β-tubulin from P. ultimum is very similar to those from Oomycetes and non-fungal organisms, many of which are sensitive to taxol. To examine the interaction between taxol and fungal microtubules, binding studies were performed with fungal cells, using [³H]taxol. The labeled taxol was found to bind specifically to P. ultimum, but not to P. microspora. In addition, the amount of [³H]taxol specifically bound to P. ultimum was reduced by the microtubule-depolymerizing drug thiabendazole, in a dose-dependent manner. These results suggest efficient binding of taxol to microtubules in P. ultimum, but not in P. microspora, and are consistent with the differential taxol sensitivity of these two organisms. Finally a comparison of previously characterized taxol binding sites in various β-tubulin sequences showed that β-tubulins of taxol-sensitive organisms, including P. ultimum, contain Thr219, but β-tubulins of resistant organisms, including P. microspora, contain Asn or Gln at this position, suggesting an important role for residue 219 in the interaction between taxol and β-tubulin.     

红豆杉内生真菌产紫杉醇相关基因BAPT的鉴定及初步研究

从几种红豆杉中先后分离了30余种内生真菌,深入研究了三种能够产紫杉醇的内生真菌。形态学观察及18srDNA鉴定它们分属于Fusarium(属)和Pestalotiopsis(属),三个菌株均可以在离体培养的条件下产生紫杉醇,经两周培养产量可分别达到8.5,31.5,31.1μg/L。(其中Pestalotiopsis1分离于南方红豆杉,Fusarium1分离于东北红豆杉,Pestalotiopsis2分离于中国红豆杉)。对这些内生真菌产紫杉醇的初步机理作了研究。BAPT(C-13phenylpropanoidsidechain-CoAacyltransferase)是红豆杉中紫杉醇合成途径里支链合成的关键酶之一,我们根据其保守区序列设计了引物,首次在能产生紫杉醇的上述三种红豆杉内生真菌中克隆得到了BAPT基因片段,而分离的其它真菌并没有得到扩增。序列分析表明,来自内生真菌的BAPT基因片段序列与红豆杉BAPT基因片段序列具有非常高的相似性(98.9%)。推测红豆杉内生真菌之所以能够合成紫杉醇,相关基因可能直接源于其宿主植物,即其遗传学起源是基因转移而不是共进化。这同时也建立了一种快速经济的鉴定产紫杉醇真菌的辅助方法。内生真菌的遗传稳定性及改良在进一步研究中。     

Analysis of beta-tubulin cDNAs from taxol-resistant Pestalotiopsis microspora and taxol-sensitive Pythium ultimum and comparison of the taxol-binding properties of their products

The anti-cancer drug taxol binds to β-tubulin in assembled microtubules and causes cell cycle arrest in animal cells; in contrast, in fungi, the effect of taxol varies. For instance, the taxol-producer Pestalotiopsis microspora Ne32, an ascomycete, is resistant to taxol (IC₅₀ greater than 11.7 μM), whereas Pythium ultimum, an oomycete, is sensitive to taxol (IC₅₀ 0.1 μM). In order to understand the differential fungal response to taxol, we isolated cDNAs encoding β-tubulin from both P. microspora and P. ultimum. The deduced amino acid sequence of β-tubulin from P. microspora is very similar to those from other Ascomycetes, many of which are resistant to taxol. The sequence of β-tubulin from P. ultimum is very similar to those from Oomycetes and non-fungal organisms, many of which are sensitive to taxol. To examine the interaction between taxol and fungal microtubules, binding studies were performed with fungal cells, using [³H]taxol. The labeled taxol was found to bind specifically to P. ultimum, but not to P. microspora. In addition, the amount of [³H]taxol specifically bound to P. ultimum was reduced by the microtubule-depolymerizing drug thiabendazole, in a dose-dependent manner. These results suggest efficient binding of taxol to microtubules in P. ultimum, but not in P. microspora, and are consistent with the differential taxol sensitivity of these two organisms. Finally a comparison of previously characterized taxol binding sites in various β-tubulin sequences showed that β-tubulins of taxol-sensitive organisms, including P. ultimum, contain Thr219, but β-tubulins of resistant organisms, including P. microspora, contain Asn or Gln at this position, suggesting an important role for residue 219 in the interaction between taxol and β-tubulin. Received: 16 March 1999 / Accepted: 21 August 1999     

Diversity and antimitotic activity of taxol-producing endophytic fungi isolated from Himalayan yew

Endophytic fungi represent an under explored resource of novel lead compounds and have the capacity to produce diverse classes of plant secondary metabolites. Here, we investigated the endophytic fungal diversity of taxol-producing endophytes from Taxus baccata L. ssp. wallichiana (Zucc.) Pilger and also tested the antimitogenic effect of fungal taxol using potato disc tumor assay. A total of 60 fungal endophytes were isolated from the inner bark (phloem-cambium) of T. baccata ssp. wallichiana, collected from different locations of the northern Himalayan region. Two key genes, DBAT (10-deacetylbaccatin III-10-O-acetyl transferase) and BAPT (C-13 phenylpropanoid side chain-CoA acyltransferase), involved in taxol biosynthesis were used as molecular markers for the screening of taxol-producing strains. Five representative species gave positive amplification hits by molecular marker screening with the bapt gene. These fungi were characterized and identified based on morphological and molecular identification. The taxol-producing capability of these endophytic fungi was validated by HPLC-MS. Among the five taxol-producing fungi, the highest yield of taxol was found to be 66.25 μg/l by Fusarium redolens compared with those of the other four strains.